Relevant publications

Papaleontiou M, Brito JP. Disentangling the Association Between Excess Thyroid Hormone and Cognition in Older Adults. JAMA Intern Med. 2023 Oct 23. Online ahead of print.

Esfandiari NH, Papaleontiou M. Levothyroxine Prescribing: Why Simple is so Complex. J Clin Endocrinol Metab. 2023 Oct 4:dgad585.

Papaleontiou M, Haymart MR. Updates in thyroid healthcare delivery: advancing patient-centered care. Curr Opin Endocrinol Diabetes Obes. 2023 Oct 1;30(5):217.

Sinclair CF, Baek JH, Hands KE, Hodak SP, Huber TC, Hussain I, Lang BH, Noel JE, Papaleontiou M, Patel KN, Russ G, Russell J, Spiezia S, Kuo JH. General Principles for the Safe Performance, Training, and Adoption of Ablation Techniques for Benign Thyroid Nodules: An American Thyroid Association Statement. Thyroid. 2023 Oct;33(10):1150-1170. 

Chen DW, Banerjee M, He X, Miranda L, Watanabe M, Veenstra CM, Haymart MR. Hidden Disparities: How Language Influences Patients' Access to Cancer Care. J Natl Compr Canc Netw. 2023 Sep;21(9):951-959.e1.

Chen DW, Banerjee M, Xu T, Worden FP, Haymart MR. Real-World Use of Systemic Therapies for the Treatment of Advanced Thyroid Cancers. Endocr Pract. 2023 Nov;29(11):868-874.

Jin X, Lew M, Pantanowitz L, Iyengar JJ, Haymart MR, Papaleontiou M, Broome D, Sandouk Z, Raja SS, Hughes DT, Smola B, Jing X. Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine-needle aspiration. Diagn Cytopathol. 2023 Nov;51(11):698-704.

Haymart P, Levin NJ, Haymart MR. The psychosocial impact of thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2023 Oct 1;30(5):252-258.

Chen DW, Worden FP, Haymart MR. Access Denied: Disparities in Thyroid Cancer Clinical Trials. J Endocr Soc. 2023 May 17;7(6):bvad064.

Agosto Salgado S, Kaye ER, Sargi Z, Chung CH, Papaleontiou M. Management of Advanced Thyroid Cancer: Overview, Advances, and Opportunities. Am Soc Clin Oncol Educ Book. 2023 May;43:e389708. 

Choksi P, Gay BL, Haymart MR, Papaleontiou M. Physician-Reported Barriers to Osteoporosis Screening: A Nationwide Survey. Endocr Pract. 2023 May 6:S1530-891X(23)00403-2.

Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023 May 6;401(10387):1531-1544. 

Busaidy NL, Leung AM, Papaleontiou M. Celebrating 20 Years of Women in Thyroidology in the American Thyroid Association. Thyroid. 2023 March 16;33(3):271-272.

Genere N, Papaleontiou M. Setting the Tone-Pretreatment Understanding Is Associated With Treatment-Related Expectations Among Thyroid Cancer Survivors. JAMA Otolaryngol Head Neck Surg. 2023 Feb 1;149(2):120-121.

Jackson Levin N, Tan CY, Stelmak D, Iannarino NT, Zhang A, Ellman E, Herrel LA, Walling EB, Moravek MB, Chugh R, Haymart MR, Zebrack B. Banking on Fertility Preservation: Financial Concern for Adolescent and Young Adult Cancer Patients Considering Oncofertility Services. J Adolesc Young Adult Oncol. 2023 Oct;12(5):710-717. 

Ullmann TM, Papaleontiou M, Sosa JA. Current Controversies in Low-Risk Differentiated Thyroid Cancer: Reducing Overtreatment in an Era of Overdiagnosis. J Clin Endocrinol Metab. 2023 Jan 17;108(2):271-280.

Haymart MR. Editorial: New horizons for thyroid diseases: transformative changes and tailored care. Curr Opin Endocrinol Diabetes Obes. 2022 Oct 1;29(5):440.

Ettleson MD, Papaleontiou M. Evaluating health outcomes in the treatment of hypothyroidism. Front Endocrinol (Lausanne). 2022 Oct 18;13:1026262.

Perkins JM, Papaleontiou M. Towards De-Implementation of low-value thyroid care in older adults. Curr Opin Endocrinol Diabetes Obes. 2022 Oct 1;29(5):483-491. 

Chiu AS, Saucke MC, Bushaw K, Voils CI, Sydnor J, Haymart M, Pitt SC. The relative importance of treatment outcomes to surgeons' recommendations for low-risk thyroid cancer. Surgery. 2023 Jan;173(1):183-188. 

Chen DW, Rob FI, Mukherjee R, Giordano TJ, Haymart MR, Banerjee M. Variation in the Diagnosis of Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features. J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4072-e4077.

Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022 Aug;20(8):925-951.

Arida AK, Papaleontiou M. To Radiate or Not to Radiate? Adjuvant External Beam Radiation Therapy for Nonanaplastic Thyroid Cancer. Endocr Pract. 2022 Jul;28(7):732-733. 

Haymart MR, Papaleontiou M. Hot Topics and Advances in Thyroidology: Looking into the Future. Endocrinol Metab Clin North Am. 2022 Jun;51(2):xv-xvi.

Evron JM, Hummel SL, Reyes-Gastelum D, Haymart MR, Banerjee M, Papaleontiou M. Association of Thyroid Hormone Treatment Intensity With Cardiovascular Mortality Among US Veterans. JAMA Netw Open. 2022 May 2;5(5):e2211863.

Chou R, Dana T, Brent GA, Goldner W, Haymart M, Leung AM, Ringel MD, Sosa JA. Serum Thyroglobulin Measurement Following Surgery Without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review. Thyroid. 2022 Jun;32(6):613-639.

Livecchi R, Coe AB, Reyes-Gastelum D, Banerjee M, Haymart MR, Papaleontiou M. Concurrent Use of Thyroid Hormone Therapy and Interfering Medications in Older US Veterans. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2738-e2742.

Chou R, Dana T, Haymart M, Leung AM, Tufano RP, Sosa JA, Ringel MD. Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. Thyroid. 2022 Apr;32(4):351-367.

Haymart MR, Papaleontiou M. Radiofrequency Ablation for Thyroid Nodules and Cancer in the United States: Balancing a Transformation of Thyroid Care With Risk for Misuse. Endocr Pract. 2022 Feb;28(2):233-234.

Bischoff L, Haymart MR. Optimal Thyrotropin Following Lobectomy for Papillary Thyroid Cancer: Does It Exist? Thyroid. 2022 Feb;32(2):117-118. 

Radhakrishnan A, Reyes-Gastelum D, Abrahamse P, Gay B, Hawley ST, Wallner LP, Chen DW, Hamilton AS, Ward KC, Haymart MR. Physician Specialties Involved in Thyroid Cancer Diagnosis and Treatment: Implications for Improving Health Care Disparities. J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1096-e1105.

Chen DW, Papaleontiou M. Clearing Up the Fog: Insights Into Brain Fog Experienced by Patients With Hypothyroidism. Endocr Pract. 2022 Mar;28(3):349-350.

Shah K, Reyes-Gastelum D, Gay BL, Papaleontiou M. Understanding Worry About Risks Associated With Thyroid Hormone Therapy: A National Survey of Endocrinologists, Family Physicians, and Geriatricians. Endocr Pract. 2022 Jan;28(1):25-29. 

Haymart MR. Year in Thyroidology-Recent Developments and Future Challenges: Clinical Science Review. Thyroid. 2022 Jan;32(1):9-13.

Haymart MR. Progress and Challenges in Thyroid Cancer Management. Endocr Pract. 2021 Dec;27(12):1260-1263.

Stan MN, Papaleontiou M, Schmitz JJ, Castro MR. Non-surgical management of thyroid nodules - the role of ablative therapies. J Clin Endocrinol Metab.  2022 Apr 19;107(5):1417-1430.

Jackson Levin N, Zhang A, Reyes-Gastelum D, Chen DW, Hamilton AS, Zebrack B, Haymart MR. Change in worry over time among Hispanic women with thyroid cancer. J Cancer Surviv. 2022 Aug;16(4):844-852.

Evron JM, Papaleontiou M. Decision Making in Subclinical Thyroid Disease. Med Clin North Am. 2021 Nov;105(6):1033-1045. 

Advani PG, Morton LM, Kitahara CM, Berrington de Gonzalez A, Ramin C, Haymart MR, Curtis RE, Schonfeld SJ. Assessment of surveillance versus etiologic factors in the reciprocal association between papillary thyroid cancer and breast cancer. Cancer Epidemiol. 2021 Jul 16;74:101985. 

Papaleontiou M, Levine DA, Reyes-Gastelum D, Hawley ST, Banerjee M, Haymart MR. Thyroid Hormone Therapy and Incident Stroke. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3890-e3900.

Pitt SC, Haymart MR. Breaking Down or Waking Up? Psychological Distress and Sleep Disturbance in Patients with Thyroid Nodules and Cancer. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e4278-e4280.

Rosko AJ, Gay BL, Reyes-Gastelum D, Hamilton AS, Ward KC, Haymart MR. Surgeons' Attitudes on Total Thyroidectomy vs Lobectomy for Management of Papillary Thyroid Microcarcinoma. JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):667-669.

Papaleontiou M, Chen D, Banerjee M, Reyes-Gastelum D, Hamilton AS, Ward KC, Haymart MR. Thyrotropin Suppression for Papillary Thyroid Cancer: A Physician Survey Study. Thyroid. 2021 Sep;31(9):1383-1390.

Papaleontiou M, Norton EC, Reyes-Gastelum D, Banerjee M, Haymart MR. Competing Causes of Death in Older Adults with Thyroid Cancer. Thyroid. 2021 Sep;31(9):1359-1365.

Wallner LP, Banerjee M, Reyes-Gastelum D, Hamilton AS, Ward KC, Lubitz C, Hawley ST, Haymart MR. Multi-level factors associated with more intensive use of radioactive iodine for low-risk thyroid cancer. J Clin Endocrinol Metab. 2021 May 13;106(6):e2402-e2412. 

Chen DW, Reyes-Gastelum D, Hawley ST, Wallner LP, Hamilton AS, Haymart MR. Unmet Information Needs Among Hispanic Women with Thyroid Cancer. J Clin Endocrinol Metab. 2021  Jun 16;106(7):e2680-e2687.

Choksi P, Gay BL, Reyes-Gastelum D, Haymart MR, Papaleontiou M. Understanding Osteoporosis Screening Practices in Men: A Nationwide Physician Survey. Endocr Pract. 2020 Nov;26(11):1237-1243. 

Kovatch KJ, Reyes-Gastelum D, Sipos JA, Caoili EM, Hamilton AS, Ward KC, Haymart MR. Physician Confidence in Neck Ultrasonography for Surveillance of Differentiated Thyroid Cancer Recurrence. JAMA Otolaryngol Head Neck Surg. 2020 Dec 23;147(2):166-72.

Hughes DT, Reyes-Gastelum D, Ward KC, Hamilton AS, Haymart MR. Barriers to the Use of Active Surveillance for Thyroid Cancer Results of a Physician Survey. Ann Surg. 2022 Jul 1;276(1):e40-e47.

Haymart MR, Goldner WS. Thyroid Cancer Clinical Guidelines and the De-escalation of Care. JAMA Otolaryngol Head Neck Surg. 2020 Nov 1;146(11):1082-1083. 

Papaleontiou M, Zebrack B, Reyes-Gastelum D, Rosko AJ, Hawley ST, Hamilton AS, Ward KC, Haymart MR. Physician management of thyroid cancer patients' worry. J Cancer Surviv. 2021 Jun;15(3):418-426. 

Chen DW, Reyes-Gastelum D, Veenstra CM, Hamilton AS, Banerjee M, Haymart MR. Financial Hardship Among Hispanic Women with Thyroid Cancer. Thyroid. 2021 May;31(5):752-759.

Singer MC, Marchal F, Angelos P, Bernet V, Boucai L, Buchholzer S, Burkey B, Eisele D, Erkul E, Faure F, Freitag SK, Gillespie MB, Harrell RM, Hartl D, Haymart M, Leffert J, Mandel S, Miller BS, Morris J, Pearce EN, Rahmati R, Ryan WR, Schaitkin B, Schlumberger M, Stack BC, Van Nostrand D, Wong KK, Randolph G. Salivary and lacrimal dysfunction after radioactive iodine for differentiated thyroid cancer: American Head and Neck Society Endocrine Surgery Section and Salivary Gland Section joint multidisciplinary clinical consensus statement of otolaryngology, ophthalmology, nuclear medicine and endocrinology. Head Neck. 2020 Nov;42(11):3446-3459.

Chen DW, Reyes-Gastelum D, Radhakrishnan A, Hamilton AS, Ward KC, Haymart MR. Physician-Reported Misuse of Thyroid Ultrasonography. JAMA Surg. 2020 Oct 1;155(10):984-986.

Radhakrishnan A, Reyes-Gastelum D, Gay B, Hawley ST, Hamilton AS, Ward KC, Wallner LP, Haymart MR. Primary care provider involvement in thyroid cancer survivorship care. J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3300–6.

Chen DW, Haymart MR. Disparities Research in Thyroid Cancer: Challenges and Strategies for Improvement. Thyroid. 2020 Sep;30(9):1231-1235.

Haymart MR, Reyes-Gastelum D, Caoili E, Norton EC, Banerjee M. The Relationship Between Imaging and Thyroid Cancer Diagnosis and Survival. Oncologist. 2020 Sep;25(9):765-771.

Papaleontiou M, Evron JM, Esfandiari NH, Reyes-Gastelum D, Ward KC, Hamilton AS, Worden F, Haymart MR. Patient Report of Recurrent and Persistent Thyroid Cancer. Thyroid. 2020 Sep;30(9):1297-1305.

Papaleontiou M, Reyes-Gastelum D, Haymart MR. Fragility Fractures in Male Veterans on Thyroid Hormone Therapy. Endocr Pract. 2020 Mar;26(3):359-361.

Papaleontiou M, Haymart MR. Too Much of a Good Thing? A Cautionary Tale of Thyroid Cancer Overdiagnosis and Overtreatment. Thyroid. 2020 May;30(5):651-652.

Pandya A, Caoili EM, Jawad-Makki F, Wasnik AP, Shankar PR, Bude R, Haymart MR, Davenport MS. Retrospective Cohort Study of 1947 Thyroid Nodules: A Comparison of the 2017 American College of Radiology TI-RADS and the 2015 American Thyroid Association Classifications. AJR Am J Roentgenol. 2020 Apr;214(4):900-906.

Chen DW, Reyes-Gastelum D, Wallner LP, Papaleontiou M, Hamilton AS, Ward KC, Hawley ST, Zikmund-Fisher BJ, Haymart MR. Disparities in risk perception of thyroid cancer recurrence and death. Cancer. 2020 Apr 1;126(7):1512-1521.

Sawka AM, Gagliardi AR, Haymart MR, Sturgeon C, Bernet V, Hoff KC, Angelos P, Brito JP, Haugen BR MD, Kim BW, Kopp PA, Mandel SJ, Ross DS, Samuels M, Sarne DH MD, Sinclair CF, Jonklaas J. A Survey of American Thyroid Association Members Regarding the 2015 Adult Thyroid Nodule and Differentiated Thyroid Cancer Clinical Practice Guidelines. Thyroid. 2020 Jan;(1):25-33.

Papaleontiou M, Haymart MR. Thyroid nodules and cancer during pregnancy, post-partum and preconception planning: Addressing the uncertainties and challenges. Best Pract Res Clin Endocrinol Metab. 2019 Nov 22:101363.

Hughes DT, Reyes-Gastelum D, Kovatch KJ, Hamilton AS, Ward KC, Haymart MR. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes. Surgery. 2020 Jan;167(1):102-109.

Evron JM, Reyes-Gastelum D, Banerjee M, Scherer LD, Wallner LP, Hamilton AS, Ward KC, Hawley ST, Zikmund-Fisher BJ, Haymart MR. Role of Patient Maximizing-Minimizing Preferences in Thyroid Cancer Surveillance. J Clin Oncol. 2019 Nov 10;37(32):3042-3049.

Esfandiari NH, Reyes-Gastelum D, Hawley ST, Haymart MR, Papaleontiou M. Patient Requests for Tests and Treatments Impact Physician Management of Hypothyroidism. Thyroid. 2019 Nov;29(11):1536-1544.

Esfandiari NH, Hughes DT, Reyes-Gastelum D, Ward KC, Hamilton AS, Haymart MR. Factors Associated With Diagnosis and Treatment of Thyroid Microcarcinomas. J Clin Endocrinol Metab. 2019 Dec 1;104(12):6060-6068.

Kovatch KJ, Reyes-Gastelum D, Hughes DT, Hamilton AS, Ward KC, Haymart MR. Assessment of Voice Outcomes Following Surgery for Thyroid Cancer. JAMA Oto. 2019 Sep 1;145(9):823-829.

Wallner LP, Reyes-Gastelum D, Hamilton AS, Ward KC, Hawley ST, Haymart MR. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer. J Clin Oncol. 2019 Aug 20;37(24):2152-2161.

Papaleontiou M, Reyes-Gastelum D, Gay BL, Ward KC, Hamilton AS, Hawley ST, Haymart MR. Worry in Thyroid Cancer Survivors with a Favorable Prognosis. Thyroid. 2019 Aug;29(8):1080-1088.

Papaleontiou M, Banerjee M, Reyes-Gastelum D, Hawley ST, Haymart MR. Risk of Osteoporosis and Fractures in Patients with Thyroid Cancer: A Case-Control Study in U.S. Veterans. Oncologist. 2019 Sep;24(9):1166-1173.

Korevaar TIM, Haymart MR. A History of Thyroid Cancer Does Not Meaningfully Complicate Pregnancy. Thyroid. 2019;29(6):758-759.

Meltzer CJ, Irish J, Angelos P, Busaidy NL, Davies L, Dwojak S, Ferris RL, Haugen BR, Harrell RM, Haymart MR, McIver B, Mechanick JI, Monteiro E, Morris JC 3rd, Morris LGT, Odell M, Scharpf J, Shaha A, Shin JJ, Shonka DC Jr, Thompson GB, Tuttle RM, Urken ML, Wiseman SM, Wong RJ, Randolph G. American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules. Head Neck. 2019;41(4):843-856.

Haddad RI, Nasr C, Bischoff L, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Goldner W, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, McIver B, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sippel R, Smallridge RC, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Johnson-Chilla A, Hoffmann KG, Gurski LA. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018. JNCCN. 2018;16(12):1429-1440.

Haymart MR, Banerjee M, Reyes-Gastelum D, Caoili E, Norton EC. Thyroid Ultrasound and the Increase in Diagnosis of Low-Risk Thyroid Cancer. J Clin Endocrinol Metab.2019;104(3):785-792.

Haymart MR. Association of the Word Cancer With Thyroid Cancer Treatment Decisions-A Rose by Any Other Name. JAMA Oto. 2018;144(10):896.

Haymart MR, Davies L. South Korean Thyroid Cancer Trends: Good News and Bad. Thyroid. 2018;28(9):1081-1082.

Pandya A, Caoili EM, Jawad-Makki F, Wasnik AP, Shankar PR, Bude R, Haymart MR, Davenport MS. Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1,947 Consecutive Aspirations. J Clin Endocrinol Metab. 2018;103(9):3496-3502.

Banerjee M, Reyes-Gastelum D, Haymart MR. Treatment-Free Survival in Patients With Differentiated Thyroid Cancer. J Clin Endocrinol Metab. 2018;103(7):2720-2727.

Haymart MR. Is BRAF V600E Mutation the Explanation for Age-Associated Mortality Risk in Patients With Papillary Thyroid Cancer? J Clin Oncol. 2018;36(5):433-434.

Haymart MR, Miller DC, Hawley ST. Active Surveillance for Low-Risk Cancers - A Viable Solution to Overtreatment? N Engl J Med. 2017;377(3):203-206.

Haymart MR, Esfandiari NH, Stang MT, Sosa JA. Controversies in the Management of Low-Risk Differentiated Thyroid Cancer. Endocr Rev. 2017;38(4):351-378.

Papaleontiou M, Gauger PG, Haymart MR.  Referral of Older Thyroid Cancer Patients to a High-Volume Surgeon: Results of a Multidisciplinary Physician Survey. Endocr Pract. 2017;23(7):808-815.

Papaleontiou M, Hughes DT, Guo C, Banerjee M, Haymart MR. Population-Based Assessment of Complications following Surgery for Thyroid Cancer. J Clin Endocrinol Metab. 2017;102(7):2543-2551.

Choksi P, Papaleontiou M, Guo C, Worden F, Banerjee M, Haymart M. Skeletal Complications and Mortality in Thyroid Cancer: A Population-Based Study. J Clin Endocrinol Metab. 2017;102(4):1254-1260.

Haymart MR, Pearce EN. How Much Should Thyroid Cancer Impact Plans for Pregnancy? Thyroid. 2017;27(3):312-314.

Papaleontiou M, Haymart MR. Inappropriate use of Suppressive Doses of Thyroid Hormone in Thyroid Nodule Management: Results from a Nationwide Survey. Endo Pract. 2016;22(11):1358-1360.

Banerjee M, Wiebel JL, Guo C, Gay B, Haymart MR. Use of imaging tests after primary treatment of thyroid cancer in the United States: Population based retrospective cohort study evaluating death and recurrence. BMJ, 2016;354:i3839.

Manohar PM, Beesley LJ, Taylor JM, Hesseltine E, Haymart MR, Esfandiari NH, Hanauer DA, Worden FP. Retrospective Study of Sirolimus and Cyclophosphamide in Patients with Advanced Differentiated Thyroid Cancers. J Thyroid Disord Ther. 2015;4(3);188.

Papaleontiou M, Gay BL, Esfandiari NH, Hawley ST, Haymart MR. The Impact of age in the Management of Hypothyroidism: Results of a Nationwide Survey. Endocr Pract. 2016 Jun;22(6):708-15.

Worden F, Fassnacht M, Shi Y, Hadjieva T, Bonichon F, et al. Safety and tolerability of sorafenib in patients with radioactive-refractory thyroid cancer. Endocr Relat Cancer. 2015;22(6):877-87.

Papaleonitou M, Hawley ST, Haymart MR. Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients. The Oncologist, 2016;21(2)165-71.

Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H, Haymart M, et al. NCCN Anaplastic Thyroid Carcinoma Version 2, Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 2015;13(9):1140-50.

Wiebel J, Esfandiari N, Papaleontiou M, Worden F, Haymart MR. Evaluating Positron Emission Tomography Use in Differentiated Thyroid Cancer. Thyroid, 2015;25(9):1026-32.

Marti JL, Davies L, Haymart MR, Roman BR, Tuttle RM, Morris LGT. Inappropriate use of radioactive iodine for low-risk papillary thyroid cancer in most common in regions with poor access to health care. Thyroid, 2016;25(7):865-6.

Zhao SG, Alexander NB, Djuric Z, Zhou J, Tao Y, Schipper M, Feng FY, Eisbruch A, Worden FP, Strath SJ, Jolly S. Maintaining physical activity during head and neck cancer treatment: Results of a pilot controlled trial. Head Neck. 2016 Apr;38 Suppl 1(Suppl 1):E1086-96.

Worden F. Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer. Ther Adv Med Oncol. 2014;6(6);267-79.

Swiecicki PL, Zhao L, Belile E, Sacco AG, Chepeha DB, Dobrosotskaya I, Spector M, Shuman A, Malloy K, Moyer J, McKean E, McLean S, Wolf GT, Eisbruch A, Prince M, Bradford C, Carey T, Worden FP. A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer. Invest New Drugs, 2015;33(6):1248-56.

Strojan P, Vermorken JB, Beitler JJ, Saba NF, Haigentz M Jr, Bossi P, Worden FP, Langendijk JA, Eisbruch A, Mendenhall WM, Lee AW, Harrison LB, Bradford CR, Smee R, Silver CE, Rinaldo A, Ferlito A. Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review. Head Neck. 2016 Apr;38 Suppl 1:E2151-8.

Davies L, Morris LGT, Haymart M, Chen AY, Goldenberg D, Morris J, Ogilvie JB, Terris DJ, Netterville J, Wong RJ, Randolph G.  American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: The increasing incidence of Thyroid Cancer. Endocrine Practice, 2015;21:686-96.

Wiebel JL, Banerjee M, Muenz DG, Worden FP, Haymart MR. Trends in Imaging After Diagnosis of Thyroid Cancer. Cancer, 2015;121(9):1387-94.

Tuttle RM, Haddad RI, Ball DW, Byrd D, Dickson P, Duh QY, Ehya H, Haymart M, Hoh C, Hunt JP, Iagaru A, Kandeel F, Kopp P, Lamonica DM, Lydiatt WM, McCaffrey J, Moley JF, Parks L, Raeburn CD, Ridge JA, Ringel MD, Scheri RP, Shah JP, Sherman SI, Sturgeon C, Waguespack SG, Wang TN, Wirth LJ, Hoffmann KG, Hughes M. Thyroid carcinoma, version 2.2014. J Natl Compr Canc Netw. 2014 Dec;12(12):1671-80; quiz 1680. 

Banerjee M, Muenz DG, Worden F, Wong SL, Haymart MR. Conditional Survival in Patients with Thyroid Cancer. Thyroid, 2014;24(12):1784-9.

Salama JK, Golden DW, Yom SS, Garg MK, Lawson J, McDonald MW, Quon H, Saba N, Smith RV, Worden F, et al. ACR Appropriateness Criteria thyroid carcinoma. Oral Oncol., 2014;50(6):577-86.

Singer K, Heiniger N, Thomas I, Worden FP, Menon RK, Chen M. Ectopic Cushing syndrome secondary to metastatic medullary thyroid cancer in a child with multiple endocrine neoplasia syndrome type 2B: clues to early diagnosis of the paraneoplastic syndromes. J Pediatr Endocrinol Metab., 2014;27(9-10):993-6.

Popovtzer A, Normolle D, Worden FP, Prince ME, Chepeha DB, Wolf GT, Bradford CR, Lawrence TS, Eisbruch A. Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio. Transl Oncol. 2014 Aug;7(4):479-83.

Lerario AM, Worden FP, Ramm CA, Hesseltine EA, Stadler WM, Else T, Shah MH, Agamah E, Rao K, Hammer GD. The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial. Horm Cancer. 2014 Aug;5(4):232-9.

Banerjee M, Muenz DG, Chang JT, Papaleontiou M, Haymart MR. Tree-Based Model for Thyroid Cancer Prognostication. J Clin Endocrinol Metab, 2014;99(10):3737-45.

Papaleontiou M, Haymart MR. New insights in risk stratification of differentiated thyroid cancer. Current Opinion in Oncology, 2014;26(1):1-7.

Esfandiari NH, Hughes DT, Banerjee M, Haymart MR. The Effect of Extent of Surgery and Number of Lymph Node Metastases on Overall Survival in Patients with Medullary Thyroid Cancer. J Clin Encrinol Metab, 2014;99(2):448-54.

Haymart MR, Banerjee M, Yin H, Worden F, Griggs JJ.  Marginal treatment benefit in anaplastic thyroid cancer. Cancer, 2013;119(17):3133-39.

Chandrasekhar SS, Randolph GW, Seidman MD, Rosenfeld RM, Angelos P, et al. Clinical practice guideline: improving voice outcomes after thyroid surgery. Otolaryngol Head Neck Surg, 2013;148(6 Suppl):S1-37.

Haymart MR, Banerjee M, Yang D, Stewart AK, Doherty GM, Koenig RJ, Griggs JJ. The Relationship Between Extent of Thyroid Cancer Surgery and Use of Radioactive Iodine. Ann Surg, 2013;258(2):354-8.

Haymart MR, Banerjee M, Yang D, Stewart AK, Sisson JC, Koenig RJ, Doherty GM, Griggs JJ. Variation in the Management of Thyroid Cancer. J Clin Endocrinol Metab, 2013;98(5):2001-8.

Haymart MR, Banerjee M, Yang D, Stewart AK, Griggs JJ, Sisson JC, Koenig RJ. Referral patterns for patients with high-risk thyroid cancer. Endocr Pract, 2013;19(4):638-43.

Haymart MR, Muenz DG, Stewart AK, Griggs JJ, Banerjee M. Disease severity and radioactive iodine use for thyroid cancer. J Clin Endocrinol Metab, 2013;98(2):678-86.

Schuessler KM, Banerjee M, Yang D, Stewart AK, Doherty GM, Haymart MR. Surgeon training and use of radioactive iodine in stage I thyroid cancer patients. Ann Surg Oncol, 2013;20(3):733-8.

Papaleontiou M, Banerjee M, Yang D, Sisson JC, Koenig RJ, Haymart MR. Factors that influence radioactive iodine use for thyroid cancer. Thyroid, 2013;23(2):219-24.

Haymart MR, Banerjee M, Yang D, Stewart AK, Koenig RJ, Griggs JJ. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer, 2013;119(2):259-65.

Papaleontiou M, Haymart MR. Approach to and treatment of thyroid disorders in the elderly. Med Clin North Am, 2012; 96(2):297-310.

Stack BC Jr, Ferris RL, Goldenberg D, Haymart MR, et. al. American Thyroid Association consensus review and statement regarding the anatomy, terminology, and rationale for lateral neck dissection in differentiated thyroid cancer. Thyroid, 2012;22(5):501-8.

Haymart MR, Banerjee M, Stewart AK, Koenig RJ, Birkmeyer JD, Griggs JJ. Use of radioactive iodine for thyroid cancer. JAMA, 2011;306(7):721-8.

Hughes DT, Haymart MR, Miller BS, Gauger PG, Doherty GM. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid, 2011;21(3):231-6.

Ha HT, Lee JS, Urba S, Koenig RJ, Sisson J, Giordano T, Worden FP. A phase II study of imatinib in patients with advanced anaplastic thyroid cancer.Thyroid, 2010;20(9):975-80.

Haymart MR, Cayo M, Chen H. Papillary thyroid microcarcinomas: big decisions for a small tumor. Ann Surg Oncol, 2009;16(11):3132-9.

Haymart MR. Understanding the relationship between age and thyroid cancer. Oncologist, 2009;14(3);216-21.

Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf), 2009;71(3):434-9.

Greenblatt DY, Cayo MA, Adler JT, Ning L, Haymart MR, Kunnimalaiyaan M, Chen H. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells. Ann Surg, 2008;247(6):1036-40.

Haymart MR, Greenblatt DY, Elson DF, Chen H. The role of intraoperative frozen section if suspicious for papillary thyroid cancer. Thyroid, 2008;18(4):419-23.

Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, Chen H. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage.J Clin Endocrinol Metab, 2008;93(3):809-14.

Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, et.al. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study. J Clin Oncol. 2008;26(29):4708-13.

Kunnimalaiyaan M, Haymart MR, Chen H. Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells. Transl Oncogenomics, 2007;2:43-7.